| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.09. | Shuttle Pharmaceuticals Holdings, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 11.09. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 02.09. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.08. | Shuttle Pharmaceuticals fails to meet Nasdaq filing requirements | 5 | Investing.com | ||
| 28.08. | Shuttle Pharmaceuticals verfehlt Meldefrist der NASDAQ | 5 | Investing.com Deutsch | ||
| 28.08. | Shuttle Pharmaceuticals gets Nasdaq notice after missing 10-Q filing deadline | 1 | Seeking Alpha | ||
| 17.08. | Shuttle Pharmaceuticals Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
| SHUTTLE PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 26.06. | United Dogecoin erwirbt Mining-Flotte und strebt Betriebsaufnahme an | 15 | Investing.com Deutsch | ||
| 26.06. | United Dogecoin purchases mining fleet, targets operations start | 1 | Investing.com | ||
| 26.06. | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site | 420 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - June 26, 2026) - United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts recently acquired by Shuttle... ► Artikel lesen | |
| 25.06. | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Advances Data Centre and Power Infrastructure Strategy to Support DOGE Mining and AI Hosting | 686 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - June 25, 2026) - United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining and digital infrastructure company driven by industry experts... ► Artikel lesen | |
| 11.06. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 09.06. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern Time | 723 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - June 9, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), the owner of Molecule.ai, an artificial intelligence... ► Artikel lesen | |
| 27.05. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 14.05. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs | 930 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - May 14, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle" or the "Company") today announced the closing (the "Closing") of its previously... ► Artikel lesen | |
| 14.05. | Shuttle Pharma completes merger with United Dogecoin | 2 | Investing.com | ||
| 01.05. | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation | 943 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - May 1, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin... ► Artikel lesen | |
| 01.05. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.04. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner | 1.017 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - April 30, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin... ► Artikel lesen | |
| 26.03. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows | 699 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - March 26, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), today announced a major advancement to its... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QUANTUM BIOPHARMA | 2,640 | -7,89 % | Quantum BioPharma Signs Contract with Thermo Fisher Scientific's Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis | TORONTO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) ("Quantum BioPharma"), a biopharmaceutical company focused on developing innovative therapies and technologies... ► Artikel lesen | |
| JAGUAR HEALTH | 5,010 | -10,85 % | Jaguar Health, Inc.: Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi | Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and short bowel syndrome (SBS) for crofelemer powder... ► Artikel lesen | |
| LIPOCINE | 2,200 | +5,52 % | Canadian Approval Of Lipocine Drug Marks Progress for Oral Testosterone Options In Canada | ||
| THERAPEUTICSMD | 1,730 | +0,58 % | TherapeuticsMD, Inc. - 10-Q, Quarterly Report | ||
| ALLARITY THERAPEUTICS | 1,010 | +2,32 % | Biotech SPAC Allarity Acquisition lowers units offered by 20% ahead of $80 million IPO | ||
| EXICURE | 1,030 | +8,42 % | Exicure, Inc.: Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance | WILMINGTON, Del., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) ("Exicure" or the "Company") today announced that it expects to issue 172,058 shares of its common stock to GPCR Therapeutics... ► Artikel lesen | |
| COSMOS HEALTH | 0,291 | +2,32 % | Cosmos Health Inc.: Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million | Record nine-month revenue of approximately $54.3 million - up 19%, or $8.7 million, from $45.6 million in the same period of 2025Nine-month 2026 revenue nearly matches the whole of 2024 - when full-year... ► Artikel lesen | |
| MEDICUS PHARMA | 0,161 | +2,03 % | Medicus Pharma Ltd. - 8-K, Current Report | ||
| 60 DEGREES PHARMACEUTICALS | 1,070 | -3,60 % | 60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA | After a scheduled interim analysis of the severe babesiosis study on October 1, 2026, the DSMB recommended completing the study with the originally planned number of patients (N=33); the study remains... ► Artikel lesen | |
| SUNSHINE BIOPHARMA | 0,700 | +75,92 % | Sunshine Biopharma Inc. - S-1, General form for registration of securities | ||
| CELLYAN BIOTECHNOLOGY | 0,102 | 0,00 % | Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period | HONG KONG, July 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply... ► Artikel lesen | |
| BAYER | 43,970 | -1,06 % | dpa-AFX-Überblick: UNTERNEHMEN vom 05.10.2026 - 15.15 Uhr | ROUNDUP: Schneider Electric übernimmt Softwarespezialist PTC - Aktie fällt RUEIL-MALMAISON/BOSTON - Der Technologiekonzern Schneider Electric setzt seine Übernahmetour mit dem Kauf des US-Softwareanbieters... ► Artikel lesen | |
| MERCK KGAA | 140,15 | +0,83 % | AKTIEN IM FOKUS: Aktien aus Diagnostik- und Laborbranche gesucht | FRANKFURT (dpa-AFX) - Aktien aus dem Segment Wirkstoffforschung, Diagnostik und Laborausrüstung haben am Dienstag auf den Kauflisten von Anlegern gestanden. Den Dax führten die Papiere von Qiagen und... ► Artikel lesen | |
| ETON PHARMACEUTICALS | 54,88 | +0,20 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| NOVO NORDISK | 34,060 | +2,81 % | JPMORGAN stuft NOVO NORDISK auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Novo Nordisk auf "Neutral" mit einem Kursziel von 275 dänischen Kronen belassen. Der Pharmakonzern dürfte am 4. November starke Quartalszahlen... ► Artikel lesen |